Short-term outcomes of induction chemotherapy with docetaxel, cisplatin, and fluorouracil (TPF) in locally advanced nasopharyngeal carcinoma.

Abstract

There is an unmet need for improving survival outcomes of locally advanced nasopharyngeal carcinoma, for example, T4/ N3 stage disease. To this end, we administered induction chemotherapy (IC) with TPF (docetaxel, cisplatin, and fluorouracil) because this stage of disease is associated with a high risk of recurrence and is difficult to control with standard treatments, such as chemoradiotherapy (CRT) alone or CRT followed by adjuvant chemotherapy. The aim of this retrospective single-center study was to clarify the short-term outcomes of locally far-advanced nasopharyngeal carcinoma patients treated with IC-TPF, followed by CRT with cisplatin. Data from 11 patients were extracted from our database, indicating that the overall response rate to IC-TPF, clinical complete response rate after CRT, 1-year progression-free survival, and 1-year overall survival were 73%, 91%, 68%, and 89%, respectively. Hematological toxicity was the most common adverse event reported during IC-TPF with 64% of patients suffering grade 3 or 4 neutropenia, 55% grade 3 or 4 leucopenia and 9% febrile neutropenia. Despite the small number of patients, these data are important because there is a limited number of studies investigating IC-TPF followed by CRT in Japanese patients. This pilot study provides some indication of the short-term effectiveness and toxicity of this therapeutic approach, which may be superior to standard treatments. Long-term follow-up is warranted to assess the effectiveness of IC-TPF in terms of clinical outcome and late-phase toxicity.

• Authors: Shigemasa Takamizawa, Yoshitaka Honma, Naoya Murakami, Taisuke Mori, Hiroki Oka, Shun Yamamoto, Tairo Kashihara, Kimiteru Ito, Yuko Kubo, Atsuo Ikeda, Fumihiko Matsumoto, Go Omura, Kenya Kobayashi, Jun Itami, Ken Kato, Seiichi Yoshimoto
• Journal: Investigational new drugs (Invest New Drugs) Vol. 39 Issue 2 Pg. 564-570 (04 2021) ISSN: 1573-0646 [Electronic] United States
• PMID: 32940872 (Publication Type: Journal Article)

Chemical References

• Docetaxel
• Cisplatin
• Fluorouracil

Topics

• Adolescent
• Adult
• Aged
• Antineoplastic Combined Chemotherapy Protocols (administration & dosage, adverse effects, therapeutic use)
• Chemoradiotherapy (methods)
• Cisplatin (therapeutic use)
• Docetaxel (therapeutic use)
• Female
• Fluorouracil (therapeutic use)
• Humans
• Induction Chemotherapy (methods)
• Male
• Middle Aged
• Nasopharyngeal Carcinoma (drug therapy, mortality, pathology, therapy)
• Nasopharyngeal Neoplasms (drug therapy, mortality, pathology, therapy)
• Neoplasm Staging
• Pilot Projects
• Progression-Free Survival
• Retrospective Studies
• Young Adult